71 related articles for article (PubMed ID: 9562182)
1. Increased axon growth through astrocyte cell lines transfected with urokinase.
Muir E; Du JS; Fok-Seang J; Smith-Thomas LC; Housden ES; Rogers J; Fawcett JW
Glia; 1998 May; 23(1):24-34. PubMed ID: 9562182
[TBL] [Abstract][Full Text] [Related]
2. Axon behaviour at Schwann cell - astrocyte boundaries: manipulation of axon signalling pathways and the neural adhesion molecule L1 can enable axons to cross.
Adcock KH; Brown DJ; Shearer MC; Shewan D; Schachner M; Smith GM; Geller HM; Fawcett JW
Eur J Neurosci; 2004 Sep; 20(6):1425-35. PubMed ID: 15355310
[TBL] [Abstract][Full Text] [Related]
3. Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors.
Smith-Thomas LC; Stevens J; Fok-Seang J; Faissner A; Rogers JH; Fawcett JW
J Cell Sci; 1995 Mar; 108 ( Pt 3)():1307-15. PubMed ID: 7622613
[TBL] [Abstract][Full Text] [Related]
4. Growth and degeneration of axons on astrocyte surfaces: effects on extracellular matrix and on later axonal growth.
Ard MD; Schachner M; Rapp JT; Faissner A
Glia; 1993 Dec; 9(4):248-59. PubMed ID: 8112818
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
6. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
7. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes and axon regeneration in the central nervous system.
Fawcett J
J Neurol; 1994 Dec; 242(1 Suppl 1):S25-8. PubMed ID: 7699404
[TBL] [Abstract][Full Text] [Related]
9. An analysis of astrocytic cell lines with different abilities to promote axon growth.
Fok-Seang J; Smith-Thomas LC; Meiners S; Muir E; Du JS; Housden E; Johnson AR; Faissner A; Geller HM; Keynes RJ
Brain Res; 1995 Aug; 689(2):207-23. PubMed ID: 7583324
[TBL] [Abstract][Full Text] [Related]
10. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
11. Robust regeneration of CNS axons through a track depleted of CNS glia.
Moon LD; Brecknell JE; Franklin RJ; Dunnett SB; Fawcett JW
Exp Neurol; 2000 Jan; 161(1):49-66. PubMed ID: 10683273
[TBL] [Abstract][Full Text] [Related]
12. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
Brain; 2007 Apr; 130(Pt 4):940-53. PubMed ID: 17314203
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
Webber MM; Waghray A
Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
Smith PC; Santibañez JF; Morales JP; Martinez J
J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
17. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
Sharma RK
In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional corepressor TPA-inducible sequence 7 regulates adult axon growth through cellular retinoic acid binding protein II expression.
Dieplinger B; Schiefermeier N; Juchum-Pasquazzo M; Gstir R; Huber LA; Klimaschewski L; Vietor I
Eur J Neurosci; 2007 Dec; 26(12):3358-67. PubMed ID: 18052984
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
20. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
